glp-1 compounding crackdown news october 2025 US signals on compounded weight-loss drugs; Hims shares tumble FDA telehealth crackdown highlights role

Your doctor will generally look at three specific areas: Your Health Metrics: Your doctor assesses individual markers like blood sugar levels, body mass index (BMI), and metabolic health to determine the duration and intensity of treatment

In March 2026, 30 more warning letters went to telehealth companies

However, these results should be interpreted considering the studys limitations, including its retrospective design, the absence of a control group, and the potential for selection bias

Integrating GLP1s into a LiverFirst Treatment Strategy When considering GLP1 therapy for patients with liver complications linked to metabolic dysfunction, clinicians should assess both hepatic and metabolic status not just weight or A1C

This makes probiotics not only digestive aids but also active participants in appetite regulation